-
Product Insights
Bad Sobernheim OT Pfeldfeld Solar Park
Bad Sobernheim OT Pfeldfeld Solar Park is a solar PV project located in Rheinland-Pfalz, Germany. The project came online in 2012. Empower your strategies with our Bad Sobernheim OT Pfeldfeld Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OTS-167 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTS-167 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.OTS-167 in Metastatic Breast CancerDrug Details:OTS-167 (OTSSP-167) is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OTS-167 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTS-167 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.OTS-167 in Triple-Negative Breast Cancer (TNBC)Drug Details:OTS-167 (OTSSP-167) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ALG.APV-527 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ALG.APV-527 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ALG.APV-527 in Endometrial Cancer Drug Details: ALG.APV-527 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Surufatinib in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Surufatinib in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Surufatinib in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegtibatinase in Homocystinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pegtibatinase in Homocystinuria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pegtibatinase in Homocystinuria Drug Details: Pegtibatinase (OT-58) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MEN-1703 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MEN-1703 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MEN-1703 in Refractory Acute Myeloid Leukemia Drug Details: MEN-1703 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabedersen in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabedersen in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabedersen in Pancreatic Cancer Drug Details: Trabedersen (OT-101) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabedersen in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabedersen in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabedersen in Solid Tumor Drug Details: Trabedersen (OT-101) is under development...